melatonin has been researched along with Neuralgia in 30 studies
Neuralgia: Intense or aching pain that occurs along the course or distribution of a peripheral or cranial nerve.
Excerpt | Relevance | Reference |
---|---|---|
"In 16 healthy volunteers, 16 patients with neurogenic pain syndromes, 37 patients with idiopathic pain syndromes, and 30 depressed patients, melatonin in serum was determined at 2 a." | 7.67 | Melatonin in serum and urine in patients with idiopathic pain syndromes. ( Almay, BG; von Knorring, L; Wetterberg, L, 1987) |
"Mechanical allodynia, thermal hyperalgesia, and cold allodynia behavioral tests were performed." | 5.91 | Modulation of Melatonin in Pain Behaviors Associated with Oxidative Stress and Neuroinflammation Responses in an Animal Model of Central Post-Stroke Pain. ( Huang, AC; Kaur, T; Shyu, BC, 2023) |
"Previous study has shown that administration of melatonin into the anterior cingulate cortex contralateral to peripheral nerve injury prevented exacerbation of mechanical allodynia with a concurrent improvement of depression-like behavior in Wistar-Kyoto (WKY) rats, a genetic variation of Wistar rats." | 3.75 | A combined effect of dextromethorphan and melatonin on neuropathic pain behavior in rats. ( Chou, CW; Hernstadt, H; Lim, G; Ma, Y; Mao, J; Rusanescu, G; Sung, B; Tian, Y; Wang, S; Zhang, L, 2009) |
"In 16 healthy volunteers, 16 patients with neurogenic pain syndromes, 37 patients with idiopathic pain syndromes, and 30 depressed patients, melatonin in serum was determined at 2 a." | 3.67 | Melatonin in serum and urine in patients with idiopathic pain syndromes. ( Almay, BG; von Knorring, L; Wetterberg, L, 1987) |
"Melatonin (MLT) has been implicated in several pathophysiological states, including pain." | 2.58 | Targeting Melatonin MT2 Receptors: A Novel Pharmacological Avenue for Inflammatory and Neuropathic Pain. ( Comai, S; De Gregorio, D; Gobbi, G; Posa, L, 2018) |
"Mechanical allodynia, thermal hyperalgesia, and cold allodynia behavioral tests were performed." | 1.91 | Modulation of Melatonin in Pain Behaviors Associated with Oxidative Stress and Neuroinflammation Responses in an Animal Model of Central Post-Stroke Pain. ( Huang, AC; Kaur, T; Shyu, BC, 2023) |
"Melatonin treatment increased the expression of neuronal sirtuin1 (SIRT1) in DRGs following nerve injury." | 1.91 | Melatonin Improves Mitochondrial Dysfunction and Attenuates Neuropathic Pain by Regulating SIRT1 in Dorsal Root Ganglions. ( Chen, J; Fang, Q; Huang, H; Liu, X; Shi, Y; Wang, Y; Wu, W; Yao, M; Zeng, Y; Zhan, H; Zhang, X; Zhong, X, 2023) |
"Melatonin (MLT) has been implicated in several pathophysiological states, including pain." | 1.72 | Acute and Chronic Pain Preclinical Models to Study the Analgesic Properties of Melatonergic Compounds. ( Comai, S; De Gregorio, D, 2022) |
" However, it can also induce peripheral neuropathic pain and neurotoxicity as adverse effects." | 1.62 | Melatonin and Selenium Suppress Docetaxel-Induced TRPV1 Activation, Neuropathic Pain and Oxidative Neurotoxicity in Mice. ( Ataizi, ZS; Ertilav, K; Nazıroğlu, M; Yıldızhan, K, 2021) |
"EA of ST36 and SP6 can alleviate neuropathic pain in CCI rats, which is closely related to its effect in inhibiting the release of IL-17 from astrocytes mediated by MT2." | 1.62 | [Melatonin receptor 2 mediated spinal dorsal horn astrocytes IL-17 inhibition contributes to electroacupuncture analgesia in neuropathic pain rats]. ( Chen, QH; Dai, QX; Deng, LY; Zhou, S, 2021) |
"Melatonin (Mel) was administered to ameliorate the sleep-awake rhythm (CCI-free + Mel and CCI-misaligned + Mel)." | 1.48 | Misaligned Feeding May Aggravate Pain by Disruption of Sleep-Awake Rhythm. ( Chu, S; Gong, X; Gu, X; Liu, H; Ma, Z; Shao, X; Xu, F; Zhao, X, 2018) |
"Neuropathic pain is a severe condition with unsatisfactory treatments." | 1.46 | Single Administration of Melatonin Modulates the Nitroxidergic System at the Peripheral Level and Reduces Thermal Nociceptive Hypersensitivity in Neuropathic Rats. ( Bonazza, V; Borsani, E; Buffoli, B; Reiter, RJ; Rezzani, R; Rodella, LF, 2017) |
"A mouse model of chronic neuropathic pain induced by partial sciatic nerve ligation (PSL) was employed." | 1.40 | Piromelatine exerts antinociceptive effect via melatonin, opioid, and 5HT1A receptors and hypnotic effect via melatonin receptors in a mouse model of neuropathic pain. ( Chen, CR; Chen, L; Cheng, NN; Huang, ZL; Laudon, M; Liu, YY; Qu, WM; Urade, Y; Yin, D, 2014) |
"Melatonin was administered at 23:00 once a day." | 1.40 | Sleep deprivation aggravates median nerve injury-induced neuropathic pain and enhances microglial activation by suppressing melatonin secretion. ( Chen, CL; Chiang, RP; Huang, CT; Tsai, YJ, 2014) |
"Oral melatonin treatment further potentiated RW activity-induced cell survival in both areas of the dentate gyrus [melatonin (n = 10) versus vehicle (n = 7): dorsal, 63 ± 5." | 1.39 | Melatonin potentiates running wheel-induced neurogenesis in the dentate gyrus of adult C3H/HeN mice hippocampus. ( Dubocovich, ML; Hudson, RL; Liu, J; Somera-Molina, KC, 2013) |
"Melatonin treatment dose-dependently attenuated p-p38 MAPK levels, release of pro-inflammatory cytokines, and behavioral hypersensitivity following CCI; conversely, pinealectomy that resulted in a reduction in endogenous melatonin levels exacerbated these effects." | 1.39 | Melatonin reduces median nerve injury-induced mechanical hypersensitivity via inhibition of microglial p38 mitogen-activated protein kinase activation in rat cuneate nucleus. ( Chiang, RP; Huang, CT; Tsai, YJ, 2013) |
" Chronic administration of melatonin (2." | 1.37 | Effect of nitric oxide in protective effect of melatonin against chronic constriction sciatic nerve injury induced neuropathic pain in rats. ( Gupta, A; Kalonia, H; Kumar, A; Kumar, P; Meena, S, 2011) |
"Here we report that both mechanical allodynia and depression-like behavior were significantly exacerbated after peripheral nerve injury in Wistar-Kyoto (WKY) rats, a genetic variation of Wistar rats with demonstrable depression-like behavior." | 1.35 | Exacerbated mechanical allodynia in rats with depression-like behavior. ( Chang, Y; Guo, G; Lim, G; Lim, JA; Mao, J; Sung, B; Wang, S; Yang, L; Zeng, Q, 2008) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (3.33) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (10.00) | 29.6817 |
2010's | 14 (46.67) | 24.3611 |
2020's | 12 (40.00) | 2.80 |
Authors | Studies |
---|---|
Posa, L | 2 |
De Gregorio, D | 3 |
Lopez-Canul, M | 1 |
He, Q | 1 |
Darcq, E | 1 |
Rullo, L | 1 |
Pearl-Dowler, L | 1 |
Luongo, L | 1 |
Candeletti, S | 1 |
Romualdi, P | 1 |
Kieffer, BL | 1 |
Gobbi, G | 2 |
Comai, S | 2 |
Mokhtari, T | 1 |
Yue, LP | 1 |
Hu, L | 1 |
Kaur, T | 1 |
Huang, AC | 1 |
Shyu, BC | 1 |
Zeng, Y | 1 |
Fang, Q | 1 |
Chen, J | 1 |
Wang, Y | 1 |
Liu, X | 1 |
Zhang, X | 1 |
Shi, Y | 1 |
Zhan, H | 1 |
Zhong, X | 1 |
Yao, M | 1 |
Huang, H | 1 |
Wu, W | 1 |
Hsieh, MC | 2 |
Lai, CY | 2 |
Lin, LT | 1 |
Chou, D | 2 |
Yeh, CM | 1 |
Cheng, JK | 1 |
Wang, HH | 2 |
Lin, KH | 1 |
Lin, TB | 2 |
Peng, HY | 2 |
Ertilav, K | 1 |
Nazıroğlu, M | 1 |
Ataizi, ZS | 1 |
Yıldızhan, K | 1 |
Huang, CT | 3 |
Chen, SH | 1 |
Chang, CF | 1 |
Lin, SC | 1 |
Lue, JH | 1 |
Tsai, YJ | 3 |
Fakhri, S | 1 |
Kiani, A | 1 |
Jalili, C | 1 |
Abbaszadeh, F | 1 |
Piri, S | 1 |
Farzaei, MH | 1 |
Rastegari-Pouyani, M | 1 |
Mohammadi-Noori, E | 1 |
Khan, H | 1 |
Wang, YH | 1 |
Tang, YR | 1 |
Gao, X | 1 |
Liu, J | 2 |
Zhang, NN | 1 |
Liang, ZJ | 1 |
Li, Y | 1 |
Pan, LX | 1 |
Martínez, AL | 1 |
Brea, J | 1 |
Barro, M | 1 |
Monroy, X | 1 |
Merlos, M | 1 |
Burgueño, J | 1 |
Loza, MI | 1 |
Deng, LY | 1 |
Zhou, S | 1 |
Chen, QH | 1 |
Dai, QX | 1 |
Lin, JJ | 1 |
Lin, Y | 1 |
Zhao, TZ | 1 |
Zhang, CK | 1 |
Zhang, T | 1 |
Chen, XL | 1 |
Ding, JQ | 1 |
Chang, T | 1 |
Zhang, Z | 1 |
Sun, C | 1 |
Zhao, DD | 1 |
Zhu, JL | 1 |
Li, ZY | 1 |
Li, JL | 1 |
Ho, YC | 1 |
Chen, GD | 1 |
Galley, HF | 1 |
McCormick, B | 1 |
Wilson, KL | 1 |
Lowes, DA | 1 |
Colvin, L | 1 |
Torsney, C | 1 |
Borsani, E | 1 |
Buffoli, B | 1 |
Bonazza, V | 1 |
Reiter, RJ | 1 |
Rezzani, R | 1 |
Rodella, LF | 1 |
Xu, F | 1 |
Zhao, X | 1 |
Liu, H | 1 |
Shao, X | 1 |
Chu, S | 1 |
Gong, X | 1 |
Ma, Z | 1 |
Gu, X | 1 |
Kuthati, Y | 1 |
Lin, SH | 1 |
Chen, IJ | 1 |
Wong, CS | 1 |
Yang, CH | 1 |
Yip, HK | 1 |
Chen, HF | 1 |
Yin, TC | 1 |
Chiang, JY | 1 |
Sung, PH | 1 |
Lin, KC | 1 |
Tsou, YH | 1 |
Chen, YL | 1 |
Li, YC | 1 |
Huang, TH | 1 |
Huang, CR | 1 |
Luo, CW | 1 |
Chen, KH | 1 |
Liu, YY | 1 |
Yin, D | 1 |
Chen, L | 1 |
Qu, WM | 1 |
Chen, CR | 1 |
Laudon, M | 1 |
Cheng, NN | 1 |
Urade, Y | 1 |
Huang, ZL | 1 |
Landis, CA | 1 |
Chiang, RP | 2 |
Chen, CL | 1 |
Wang, S | 2 |
Zhang, L | 1 |
Lim, G | 2 |
Sung, B | 2 |
Tian, Y | 1 |
Chou, CW | 1 |
Hernstadt, H | 1 |
Rusanescu, G | 1 |
Ma, Y | 1 |
Mao, J | 3 |
Lin, JP | 1 |
Xia, YH | 1 |
Zhao, H | 1 |
Kumar, A | 1 |
Meena, S | 1 |
Kalonia, H | 1 |
Gupta, A | 1 |
Kumar, P | 1 |
Somera-Molina, KC | 1 |
Hudson, RL | 1 |
Dubocovich, ML | 1 |
Zeng, Q | 1 |
Yang, L | 1 |
Chang, Y | 1 |
Lim, JA | 1 |
Guo, G | 1 |
Almay, BG | 1 |
von Knorring, L | 1 |
Wetterberg, L | 1 |
2 reviews available for melatonin and Neuralgia
Article | Year |
---|---|
Melatonin and their analogs as a potential use in the management of Neuropathic pain.
Topics: Analgesics; Animals; Drug Evaluation, Preclinical; Humans; Melatonin; Neuralgia; Receptor, Melatonin | 2019 |
Targeting Melatonin MT2 Receptors: A Novel Pharmacological Avenue for Inflammatory and Neuropathic Pain.
Topics: Acetamides; Analgesics; Aniline Compounds; Animals; Brain; Clinical Studies as Topic; Humans; Inflam | 2018 |
28 other studies available for melatonin and Neuralgia
Article | Year |
---|---|
Supraspinal melatonin MT
Topics: Analgesics, Opioid; Animals; Enkephalins; Melatonin; Mice; Naloxone; Narcotic Antagonists; Neuralgia | 2022 |
Acute and Chronic Pain Preclinical Models to Study the Analgesic Properties of Melatonergic Compounds.
Topics: Acetamides; Analgesics; Animals; Chronic Pain; Melatonin; Neuralgia | 2022 |
Exogenous melatonin alleviates neuropathic pain-induced affective disorders by suppressing NF-κB/ NLRP3 pathway and apoptosis.
Topics: Animals; Anti-Inflammatory Agents; Apoptosis; bcl-2-Associated X Protein; Cytokines; Inflammasomes; | 2023 |
Modulation of Melatonin in Pain Behaviors Associated with Oxidative Stress and Neuroinflammation Responses in an Animal Model of Central Post-Stroke Pain.
Topics: Animals; Disease Models, Animal; Hyperalgesia; Inflammation; Interleukin-6; Melatonin; Neuralgia; Ne | 2023 |
Melatonin Improves Mitochondrial Dysfunction and Attenuates Neuropathic Pain by Regulating SIRT1 in Dorsal Root Ganglions.
Topics: Analgesics; Animals; Ganglia, Spinal; Hyperalgesia; Melatonin; Mitochondria; Neuralgia; Rats; Rats, | 2023 |
Melatonin Relieves Paclitaxel-Induced Neuropathic Pain by Regulating pNEK2-Dependent Epigenetic Pathways in DRG Neurons.
Topics: Animals; Epigenesis, Genetic; Ganglia, Spinal; Hyperalgesia; Melatonin; Neuralgia; Neurons; Rats; Re | 2023 |
Melatonin and Selenium Suppress Docetaxel-Induced TRPV1 Activation, Neuropathic Pain and Oxidative Neurotoxicity in Mice.
Topics: Animals; Calcium; Docetaxel; Male; Melatonin; Mice; Neuralgia; Oxidative Stress; Selenium; TRPM Cati | 2021 |
Melatonin reduces neuropathic pain behavior and glial activation through MT
Topics: Animals; Demyelinating Diseases; Lysophosphatidylcholines; Male; Melatonin; Microinjections; Neuralg | 2020 |
Intrathecal Administration of Melatonin Ameliorates the Neuroinflammation- Mediated Sensory and Motor Dysfunction in A Rat Model of Compression Spinal Cord Injury.
Topics: Animals; Disease Models, Animal; Melatonin; Neuralgia; Neuroinflammatory Diseases; Rats; Rats, Sprag | 2021 |
The anti-inflammatory and analgesic effects of intraperitoneal melatonin after spinal nerve ligation are mediated by inhibition of the NF-κB/NLRP3 inflammasome signaling pathway.
Topics: Analgesics; Animals; Anti-Inflammatory Agents; Dipeptides; Inflammasomes; Male; Melatonin; Neuralgia | 2021 |
Development of a novel in vitro assay to screen for neuroprotective drugs against iatrogenic neurite shortening.
Topics: Analgesics; Cell Line; Drug Evaluation, Preclinical; Ganglia, Spinal; Humans; Iatrogenic Disease; Me | 2021 |
[Melatonin receptor 2 mediated spinal dorsal horn astrocytes IL-17 inhibition contributes to electroacupuncture analgesia in neuropathic pain rats].
Topics: Animals; Astrocytes; Electroacupuncture; Interleukin-17; Male; Melatonin; Neuralgia; Rats; Rats, Spr | 2021 |
Melatonin Suppresses Neuropathic Pain via MT2-Dependent and -Independent Pathways in Dorsal Root Ganglia Neurons of Mice.
Topics: Animals; Behavior, Animal; Cells, Cultured; Ganglia, Spinal; Gene Expression Profiling; Melatonin; M | 2017 |
Melatonin impedes Tet1-dependent mGluR5 promoter demethylation to relieve pain.
Topics: Analgesics; Animals; Demethylation; Dioxygenases; DNA Methylation; Hyperalgesia; Male; Melatonin; Ne | 2017 |
Melatonin limits paclitaxel-induced mitochondrial dysfunction in vitro and protects against paclitaxel-induced neuropathic pain in the rat.
Topics: Animals; Antineoplastic Agents, Phytogenic; Antioxidants; Cell Line, Tumor; Female; Humans; Hyperalg | 2017 |
Single Administration of Melatonin Modulates the Nitroxidergic System at the Peripheral Level and Reduces Thermal Nociceptive Hypersensitivity in Neuropathic Rats.
Topics: Animals; Disease Models, Animal; Ganglia, Spinal; Hyperalgesia; Immunohistochemistry; Male; Melatoni | 2017 |
Misaligned Feeding May Aggravate Pain by Disruption of Sleep-Awake Rhythm.
Topics: Activity Cycles; Animals; Behavior, Animal; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Cycl | 2018 |
Long-term Therapeutic Effects of Extracorporeal Shock Wave-Assisted Melatonin Therapy on Mononeuropathic Pain in Rats.
Topics: Animals; Antioxidants; Extracorporeal Shockwave Therapy; Male; Melatonin; Neuralgia; Oxidative Stres | 2019 |
Piromelatine exerts antinociceptive effect via melatonin, opioid, and 5HT1A receptors and hypnotic effect via melatonin receptors in a mouse model of neuropathic pain.
Topics: Analgesics; Animals; Disease Models, Animal; Hyperalgesia; Hypnotics and Sedatives; Indoles; Male; M | 2014 |
Is melatonin the next "new" therapy to improve sleep and reduce pain?
Topics: Animals; Male; Median Nerve; Melatonin; Microglia; Neuralgia; Sleep Deprivation | 2014 |
Sleep deprivation aggravates median nerve injury-induced neuropathic pain and enhances microglial activation by suppressing melatonin secretion.
Topics: Animals; Cytokines; Inflammation Mediators; Male; Median Nerve; Medulla Oblongata; Melatonin; Microg | 2014 |
A combined effect of dextromethorphan and melatonin on neuropathic pain behavior in rats.
Topics: Analysis of Variance; Animals; Chronic Disease; Dextromethorphan; Dose-Response Relationship, Drug; | 2009 |
[Effect and possible mechanism of melatonin on the firing rate of pain neurons in lateral habenular nucleus].
Topics: Analgesics; Animals; Habenula; Male; Melatonin; Neuralgia; Neurons; Rats; Rats, Wistar | 2006 |
Effect of nitric oxide in protective effect of melatonin against chronic constriction sciatic nerve injury induced neuropathic pain in rats.
Topics: Animals; Antioxidants; Arginine; Catalase; Chronic Disease; Disease Models, Animal; Glutathione; Hyp | 2011 |
Melatonin potentiates running wheel-induced neurogenesis in the dentate gyrus of adult C3H/HeN mice hippocampus.
Topics: Animals; Blotting, Western; Dentate Gyrus; Enzyme-Linked Immunosorbent Assay; Immunohistochemistry; | 2013 |
Melatonin reduces median nerve injury-induced mechanical hypersensitivity via inhibition of microglial p38 mitogen-activated protein kinase activation in rat cuneate nucleus.
Topics: Animals; Blotting, Western; Enzyme-Linked Immunosorbent Assay; Immunohistochemistry; Male; Median Ne | 2013 |
Exacerbated mechanical allodynia in rats with depression-like behavior.
Topics: Animals; Depressive Disorder; Disease Models, Animal; Genetic Predisposition to Disease; Gyrus Cingu | 2008 |
Melatonin in serum and urine in patients with idiopathic pain syndromes.
Topics: Adult; Aged; Circadian Rhythm; Depressive Disorder; Female; Humans; Male; Melatonin; Middle Aged; Ne | 1987 |